A Bone‐Penetrating Precise Controllable Drug Release System Enables Localized Treatment of Osteoporotic Fracture Prevention via Modulating Osteoblast‐Osteoclast Communication
Small · 2023
DOI: 10.1002/smll.202207195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Haojun Liang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic, The Third Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, P. R. China. Hauptthemen laut MEDLINE: Osteoporotic Fractures, Osteoporosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Nova Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Improving local bone mineral density (BMD) at fracture‐prone sites of bone is a clinical concern for osteoporotic fracture prevention. In this study, a featured radial extracorporeal shock wave (rESW) responsive nano‐drug delivery system (NDDS) is developed for local treatment. Based on a mechanic simulation, a sequence of hollow zoledronic acid (ZOL)‐contained nanoparticles (HZNs) with controllable shell thickness that predicts various mechanical responsive properties is constructed by controlling the deposition time of ZOL and Ca 2+ on liposome templates. Attributed to the controllable shell thickness, the fragmentation of HZNs and the release of ZOL and Ca 2+ can be precisely controlled with the intervention of rESW. Furthermore, the distinct effect of HZNs with different shell thicknesses on bone metabolism after fragmentation is verified. In vitro co‐culture experiments demonstrate that although HZN2 does not have the strongest osteoclasts inhibitory effect, the best pro‐osteoblasts mineralization results are achieved via maintaining osteoblast‐osteoclast (OB‐OC) communication. In vivo, the HZN2 group also shows the strongest local BMD enhancement after rESW intervention and significantly improves bone‐related parameters and mechanical properties in the ovariectomy (OVX)‐induced osteoporosis (OP) rats. These findings suggest that an adjustable and precise rESW‐responsive NDDS can effectively improve local BMD in OP therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic, The Third Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, P. R. China.
- Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, 100043, P. R. China.
- State Key Laboratory of Explosion Science and Technology, Beijing Institute of Technology, Beijing, 100081, P. R. China.
ORCID-Profile: Kui Chen
Förderung
- National Key Research and Development Program of China
- Beijing Nova Program
- National Natural Science Foundation of China
Zitieren
APA
Liang, H., Chen, K., Xie, J., Yao, L., Liu, Y., Hu, F., Li, H., Lei, Y., Wang, Y., Lv, L., Chen, Z., Liu, S., Liu, Q., Wang, Z., Li, J., Chang, Y. N., Li, J., Yuan, H., Xing, G., & Xing, G. (2023). A Bone‐Penetrating Precise Controllable Drug Release System Enables Localized Treatment of Osteoporotic Fracture Prevention via Modulating Osteoblast‐Osteoclast Communication. Small. https://doi.org/10.1002/smll.202207195
Vancouver
Liang H, Chen K, Xie J, Yao L, Liu Y, Hu F, et al. A Bone‐Penetrating Precise Controllable Drug Release System Enables Localized Treatment of Osteoporotic Fracture Prevention via Modulating Osteoblast‐Osteoclast Communication. Small. 2023. doi:10.1002/smll.202207195
BibTeX
@article{Liang2023,
author = {Liang, Haojun and Chen, Kui and Xie, Jing and Yao, Lei and Liu, Yunpeng and Hu, Fan and Li, Hao and Lei, Yinze and Wang, Yujiao and Lv, Linwen and Chen, Ziteng and Liu, Sen and Liu, Qiuyang and Wang, Zhijie and Li, Jiacheng and Chang, Ya-Nan and Li, Juan and Yuan, Hui and Xing, Gengyan and Xing, Gengmei},
title = {A Bone‐Penetrating Precise Controllable Drug Release System Enables Localized Treatment of Osteoporotic Fracture Prevention via Modulating Osteoblast‐Osteoclast Communication},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202207195}
}
EUVIMED